SBI in Children With d-IBS

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 2, 2017

Conditions
Irritable Bowel Syndrome
Interventions
OTHER

Medical Food

Serum-derived bovine immunoglobulin protein isolate will be supplied by EnteraHealth. The product is manufactured in accordance with Good Manufacturing Practice (GMP) and U.S. Food and Drug Administration (FDA) guidelines for medical food ingredients (21 CFR Part 110). Serum-derived bovine immunoglobulin protein isolate (SBI) is generally recognized as safe (GRAS). The FDA has reviewed the safety dossier for SBI as a medical food product.

OTHER

Placebo

Trial Locations (1)

70118

Childrens Hospital, New Orleans

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Entera Health, Inc

INDUSTRY

lead

Louisiana State University Health Sciences Center in New Orleans

OTHER